Department of Medicine

New target for colorectal cancer

Vanderbilt investigators have discovered that activated epidermal growth factor receptor may be a target for therapies to prevent colorectal cancer development.

Overweight or obese family in the park

VUMC joins cutting-edge obesity research network

Vanderbilt University Medical Center (VUMC) is one of four centers receiving a $15 million, four-year research award from the American Heart Association (AHA) to provide cutting-edge research on obesity as part of its sixth Strategically Focused Research Network (SFRN).

Varki set for Discovery Lecture

Ajit Varki, M.D., a pioneer in the field of molecular glycobiology at the University of California, San Diego (UCSD), will deliver the next Flexner Discovery Lecture on Thursday, March 23.

American Thoracic Society lauds Young’s contributions

Lisa Young, M.D., associate professor of Pediatrics and Medicine in the Divisions of Pulmonary Medicine and Allergy, Pulmonary, and Critical Care Medicine, has been selected to receive this year’s American Thoracic Society (ATS) Public Advisory Roundtable Excellence Award.

Melanoma study finds new way to enhance targeted therapies

With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy.

middle aged african american man outdoors

Role for mouth microbes in diabetes?

A higher abundance of certain bacterial species in the mouth appears to reduce the risk of type 2 diabetes, Vanderbilt investigators have discovered.

1 71 72 73 74 75 92